APA

Liu C., Huang T., Chu P., Huang C., Lee C., Wang W., Lau K., Tsai W., Chao T., Su J., Chen M., Shiau C., Tseng L. & Chen K. (20180531). The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. : Experimental & molecular medicine.

Chicago

Liu Chun-Yu, Huang Tzu-Ting, Chu Pei-Yi, Huang Chun-Teng, Lee Chia-Han, Wang Wan-Lun, Lau Ka-Yi, Tsai Wen-Chun, Chao Tzu-I, Su Jung-Chen, Chen Ming-Huang, Shiau Chung-Wai, Tseng Ling-Ming and Chen Kuen-Feng. 20180531. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. : Experimental & molecular medicine.

Harvard

Liu C., Huang T., Chu P., Huang C., Lee C., Wang W., Lau K., Tsai W., Chao T., Su J., Chen M., Shiau C., Tseng L. and Chen K. (20180531). The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. : Experimental & molecular medicine.

MLA

Liu Chun-Yu, Huang Tzu-Ting, Chu Pei-Yi, Huang Chun-Teng, Lee Chia-Han, Wang Wan-Lun, Lau Ka-Yi, Tsai Wen-Chun, Chao Tzu-I, Su Jung-Chen, Chen Ming-Huang, Shiau Chung-Wai, Tseng Ling-Ming and Chen Kuen-Feng. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. : Experimental & molecular medicine. 20180531.